Differentiation of human bone marrow mesenchymal stem cells to chondrocytes for construction of three-dimensional cartilage tissue

被引:33
作者
Matsuda, C
Takagi, M
Hattori, T
Wakitani, S
Yoshida, T
机构
[1] Osaka Univ, Int Ctr Biotechnol, Suita, Osaka 5650871, Japan
[2] Osaka Minami Natl Hosp, Dept Orthoped Surg, Kawachi Nagano, Osaka 5868521, Japan
[3] Shinshu Univ, Sch Med, Matsumoto, Nagano 3908621, Japan
[4] Hokkaido Univ, Grad Sch Engn, Div Biotechnol & Mol Chem, Sapporo, Hokkaido 0608628, Japan
关键词
chondrocyte; differentiation; mesenchymal stem cell; three-dimension;
D O I
10.1007/s10616-005-3751-x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A differentiation method of human bone marrow mesenchymal stem cells (MSCs) to chondrocytes was developed for the construction of a three-dimensional (3D) cartilage tissue. The adhesive cells, which were isolated from a human bone marrow aspirate were embedded in type I collagen in a poly-(L)-lactate-glycolic acid copolymer (PLGA) mesh and cultivated for 4 week together with growth factors. The degree of cellular differentiation was estimated by quantitative RT-PCR of aggrecan and type II collagen mRNAs and by staining with Safranin O. The 3D culture showed a higher degree of differentiation even without growth factors than the conventional pellet culture with growth factors, namely, dexamethasone and transforming growth factor (TGF)-beta 3. The 3D culture for 2 week with the combined addition of dexamethasone, TGF-beta 3, and insulin-like growth factor (IGF)-I reached a 30% expression of aggrecan mRNA compared with that in primary human chondrocytes, while the aggrecan mRNA expression in the conventional pellet culture was less than 2%. The sequential two-step differentiation cultivation, during which the cells were cultivated in 3D for 1 week after the conventional two-dimensional (2D) culture for 1 week, could markedly accelerate the expression of aggrecan mRNA compared with the 3D cultivation for 2 week.
引用
收藏
页码:11 / 17
页数:7
相关论文
共 23 条
[1]  
Alastair M. M., 1998, TISSUE ENG, V4, P415
[2]  
ALLISON A, 2001, J ORTHOP RES, V19, P738
[3]  
ALLISON AW, 2000, AM J VET RES, V9, P1003
[4]   The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105) [J].
Barry, FP ;
Boynton, RE ;
Haynesworth, S ;
Murphy, JM ;
Zaia, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 265 (01) :134-139
[5]  
Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO
[6]  
2-F
[7]   Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells [J].
Bruder, SP ;
Kurth, AA ;
Shea, M ;
Hayes, WC ;
Jaiswal, N ;
Kadiyala, S .
JOURNAL OF ORTHOPAEDIC RESEARCH, 1998, 16 (02) :155-162
[8]   MESENCHYMAL STEM-CELLS [J].
CAPLAN, AI .
JOURNAL OF ORTHOPAEDIC RESEARCH, 1991, 9 (05) :641-650
[9]  
Caplan Arnold I., 1993, P405
[10]  
Dennis JE, 1996, J CELL PHYSIOL, V167, P523, DOI 10.1002/(SICI)1097-4652(199606)167:3<523::AID-JCP16>3.0.CO